Therapeutic Areas
Production Capacity
The two state-of-the-art manufacturing units within our plant, are segregated and dedicated to the production of conventional solid dosage forms and oncology solid dosage forms.
Conventional: 500M tablets, 40M capsules
Oncology: 140M tablets, 10M capsules
Global Presence
While GENEPHARM retains its position in the Greek market, having established solid relationships with local physicians and patients, our business extends globally via strategic alliances, based on the development of new products and our continuous investment in state-of-the-art infrastructure and technologies.
Today, our presence extends to over 80 countries through our collaboration with some of the most respected pharmaceutical companies in the world.
Establishment
Production
Certifications
